688488 Stock Overview
Develops, produces, and sells pharmaceutical products. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Jiangsu Aidea Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥8.43 |
| 52 Week High | CN¥17.40 |
| 52 Week Low | CN¥6.58 |
| Beta | 0.41 |
| 1 Month Change | -7.97% |
| 3 Month Change | 18.23% |
| 1 Year Change | -30.79% |
| 3 Year Change | -43.84% |
| 5 Year Change | n/a |
| Change since IPO | -72.74% |
Recent News & Updates
Recent updates
Unpleasant Surprises Could Be In Store For Jiangsu Aidea Pharmaceutical Co., Ltd.'s (SHSE:688488) Shares
Oct 16
Jiangsu Aidea Pharmaceutical Co., Ltd.'s (SHSE:688488) 30% Share Price Plunge Could Signal Some Risk
Jun 29Jiangsu Aidea Pharmaceutical (SHSE:688488) Is Making Moderate Use Of Debt
Jun 07Jiangsu Aidea Pharmaceutical Co., Ltd.'s (SHSE:688488) Shares Climb 27% But Its Business Is Yet to Catch Up
Mar 01Shareholder Returns
| 688488 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | -9.1% | -1.9% | -1.2% |
| 1Y | -30.8% | -16.2% | 11.8% |
Return vs Industry: 688488 underperformed the CN Biotechs industry which returned -16.2% over the past year.
Return vs Market: 688488 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
| 688488 volatility | |
|---|---|
| 688488 Average Weekly Movement | 10.1% |
| Biotechs Industry Average Movement | 8.8% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 688488 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688488's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 491 | Jie Zhang | www.aidea.com.cn |
Jiangsu Aidea Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products. It offers ainuovirine tablets; urinary protein products, including crude product/intermediate of ulinastatin, urinary kallidinogenase, and urokinase; sennae folium granules; and HIV diagnostic equipment and reagents. The company was founded in 2009 and is headquartered in Yangzhou, China.
Jiangsu Aidea Pharmaceutical Co., Ltd. Fundamentals Summary
| 688488 fundamental statistics | |
|---|---|
| Market cap | CN¥3.55b |
| Earnings (TTM) | -CN¥104.55m |
| Revenue (TTM) | CN¥408.68m |
8.7x
P/S Ratio-33.9x
P/E RatioIs 688488 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688488 income statement (TTM) | |
|---|---|
| Revenue | CN¥408.68m |
| Cost of Revenue | CN¥227.38m |
| Gross Profit | CN¥181.30m |
| Other Expenses | CN¥285.85m |
| Earnings | -CN¥104.55m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.25 |
| Gross Margin | 44.36% |
| Net Profit Margin | -25.58% |
| Debt/Equity Ratio | 41.4% |
How did 688488 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 22:19 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jiangsu Aidea Pharmaceutical Co., Ltd. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yuan Yuan Sun | Industrial Securities Co. Ltd. |
| Song Yang | Tianfeng Securities Brokerage Co., Ltd |